Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain
Samira Abu Jhaisha, Esti Widowati, Isao Kii, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis
Amina Jamal Laham, Maha Saber-Ayad, Raafat El‐Awady
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 2, pp. 603-619
Open Access | Times Cited: 63
Pathogenic, Total Loss-of-Function DYRK1B Variants Cause Monogenic Obesity Associated With Type 2 Diabetes
Lise Folon, Morgane Baron, Victoria Scherrer, et al.
Diabetes Care (2024) Vol. 47, Iss. 3, pp. 444-451
Open Access | Times Cited: 6
A wake‐up call to quiescent cancer cells – potential use of DYRK1B inhibitors in cancer therapy
Walter Becker
FEBS Journal (2017) Vol. 285, Iss. 7, pp. 1203-1211
Open Access | Times Cited: 55
Druggable Transient Pockets in Protein Kinases
Koji Umezawa, Isao Kii
Molecules (2021) Vol. 26, Iss. 3, pp. 651-651
Open Access | Times Cited: 32
Inhibition of DYRK1B suppresses inflammation in allergic contact dermatitis model and Th1/Th17 immune response
Thamrong Wongchang, Panwadee Pluangnooch, Suradej Hongeng, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Emerging Roles of DYRK Kinases in Embryogenesis and Hedgehog Pathway Control
Rajeev Singh, Matthias Lauth
Journal of Developmental Biology (2017) Vol. 5, Iss. 4, pp. 13-13
Open Access | Times Cited: 34
Mirk/Dyrk1B Kinase Inhibitors in Targeted Cancer Therapy
Nikolaos Kokkorakis, Marios Zouridakis, Maria Gaitanou
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 528-528
Open Access | Times Cited: 3
Functional characterization of DYRK1A missense variants associated with a syndromic form of intellectual deficiency and autism
Esti Widowati, Sabrina Ernst, Ralf Hausmann, et al.
Biology Open (2018) Vol. 7, Iss. 4
Open Access | Times Cited: 29
Proline Hydroxylation Primes Protein Kinases for Autophosphorylation and Activation
Sang Bae Lee, Aram Ko, Young Taek Oh, et al.
Molecular Cell (2020) Vol. 79, Iss. 3, pp. 376-389.e8
Open Access | Times Cited: 27
DYRK1B inhibition exerts senolytic effects on endothelial cells and rescues endothelial dysfunctions
Francesca Michela Pramotton, Asra Abukar, Chantelle Hudson, et al.
Mechanisms of Ageing and Development (2023) Vol. 213, pp. 111836-111836
Open Access | Times Cited: 8
Systems biology approach to identify biomarkers and therapeutic targets for colorectal cancer
Niloufar Sadat Kalaki, Mozhgan Ahmadzadeh, Mohammad Najafi, et al.
Biochemistry and Biophysics Reports (2024) Vol. 37, pp. 101633-101633
Open Access | Times Cited: 2
Development of novel amide–derivatized 2,4-bispyridyl thiophenes as highly potent and selective Dyrk1A inhibitors. Part II: Identification of the cyclopropylamide moiety as a key modification
Sarah S. Darwish, Mohammad Abdel‐Halim, Ahmed K. ElHady, et al.
European Journal of Medicinal Chemistry (2018) Vol. 158, pp. 270-285
Closed Access | Times Cited: 21
Mirk/Dyrk1B controls ventral spinal cord development via Shh pathway
Nikolaos Kokkorakis, Katerina Douka, A. Nalmpanti, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
A Bioinformatics Evaluation of the Role of Dual-Specificity Tyrosine-Regulated Kinases in Colorectal Cancer
Amina Jamal Laham, Raafat El‐Awady, Jean‐Jacques Lebrun, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 2034-2034
Open Access | Times Cited: 10
Identification of FAM53C as a cytosolic-anchoring inhibitory binding protein of the kinase DYRK1A
Yoshihiko Miyata, Eisuke Nishida
Life Science Alliance (2023) Vol. 6, Iss. 12, pp. e202302129-e202302129
Open Access | Times Cited: 5
DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
Mina Yousefelahiyeh, Jingyi Xu, Estibaliz Alvarado, et al.
PLoS ONE (2018) Vol. 13, Iss. 11, pp. e0207779-e0207779
Open Access | Times Cited: 15
Minibrain-related kinase/dual-specificity tyrosine-regulated kinase 1B implication in stem/cancer stem cells biology
Nikolaos Kokkorakis, Maria Gaitanou
World Journal of Stem Cells (2020) Vol. 12, Iss. 12, pp. 1553-1575
Open Access | Times Cited: 12
Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
Marco Papenfuss, Svenja Lützow, Gerrit Wilms, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Acquired and modifiable cardiovascular risk factors in patients treated for cancer
Gary S. Beasley, Jeffrey A. Towbin
Journal of Thrombosis and Thrombolysis (2020) Vol. 51, Iss. 4, pp. 846-853
Closed Access | Times Cited: 7
Two novel variants in DYRK1B causative of AOMS3: expanding the clinical spectrum
Elvia Mendoza‐Caamal, Francisco Barajas‐Olmos, Elaheh Mirzaeicheshmeh, et al.
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 7
Protein quality control of DYRK family protein kinases by the Hsp90-Cdc37 molecular chaperone
Yoshihiko Miyata, Eisuke Nishida
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2021) Vol. 1868, Iss. 10, pp. 119081-119081
Closed Access | Times Cited: 6
Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
Esti Widowati, Simone Bamberg‐Lemper, Walter Becker
BMC Research Notes (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Functional characterization of two DYRK1B variants causative of AOMS3
Silvia Detro‐Dassen, Anna R. Sternberg, S. Lehmann, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access
Abdominal Obesity–Metabolic Syndrome 3 Misclassified as Type 1 Diabetes Mellitus
Suhaib Radi, Lujain Faisal Bashamakh, Hayfa Mandourah, et al.
JCEM Case Reports (2024) Vol. 2, Iss. 8
Open Access
Elevated expression levels of the protein kinase DYRK1B induce mesenchymal features in A549 lung cancer cells
Soraya Sester, Gerrit Wilms, Joana Ahlburg, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top